Ascletis Pharma Inc.

Ascletis Pharma Inc. - Enterprise Valueverified

ASCLF

Price:

$1.205

Market Cap:

$8.99B

Ascletis Pharma Inc., a biotechnology company, engages in the research and development, manufacture, marketing, and sale of pharmaceutical products in Mainland China. The company's commercial products include Ritonavir tablet; and ASCLEVIR and GANOVO for use in the treatment of Hepatitis C virus. It is also developing ASC22 for treating CHB and HIV functional cure; ASC10 for treating respiratory syncytia virus; ASC10 and ASC11 to treat COVID-19; ASC40, ASC41, and ASC43F FDC for non-alcoholic steatohepatitis; and ASC42 for the treatment of primary biliary cholangitis. In addition, the company is developing ASC40 to treat recurrent glioblastoma; ASC61 for advanced solid tumors; and ASC40, an o...[Read more]

Industry

Biotechnology

IPO Date

2019-11-19

Stock Exchange

OTC

Ticker

ASCLF

The Enterprise Value as of August 2026 (TTM) for Ascletis Pharma Inc. (ASCLF) is 7.55B

According to Ascletis Pharma Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 7.55B. This represents a change of 72.92% compared to the average of 4.36B of the last 4 quarters.

Ascletis Pharma Inc. (ASCLF) Historical Enterprise Value (quarterly & annually)

How has ASCLF Enterprise Value performed in the past?

The mean historical Enterprise Value of Ascletis Pharma Inc. over the last ten years is 4.13B. The current 7.55B Enterprise Value has changed 18.16% with respect to the historical average. Over the past ten years (40 quarters), ASCLF's Enterprise Value was at its highest in in the June 2017 quarter at 14.04B. The Enterprise Value was at its lowest in in the December 2020 quarter at -195984355.22.

Quarterly (TTM)
Annual

Average

4.13B

Median

1.83B

Minimum

-192427209.33

Maximum

13.62B

Ascletis Pharma Inc. (ASCLF) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Ascletis Pharma Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 364.81%

Maximum Annual Enterprise Value = 13.62B

Minimum Annual Increase = -332.90%

Minimum Annual Enterprise Value = -192427209.33

Quarterly (TTM)
Annual
YearEnterprise ValueChange
20258.51B331.25%
20241.97B109.15%
2023943.53M-54.71%
20222.08B364.81%
2021448.16M-332.90%
2020-192427209.332.61%
2019-187534024.49-111.13%
20181.68B-86.47%
201712.45B-8.60%

Ascletis Pharma Inc. (ASCLF) Average Enterprise Value

How has ASCLF Enterprise Value performed in the past?

The current Enterprise Value of Ascletis Pharma Inc. (ASCLF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

3.81B

5-year avg

2.79B

10-year avg

4.13B

Ascletis Pharma Inc. (ASCLF) Enterprise Value vs. Peers

How is ASCLF’s Enterprise Value compared to its peers?

Ascletis Pharma Inc.’s Enterprise Value is less than SanBio Company Limited (62.96B), greater than CStone Pharmaceuticals (6.13B), greater than Pharming Group N.V. (727.15M), greater than Idorsia Ltd (2.82B), less than Paramount Bed Holdings Co., Ltd. (170.12B), less than SSY Group Limited (9.24B), less than BioGaia AB (publ) (10.61B), less than Tobii Dynavox AB (publ) (8.90B), less than Life Healthcare Group Holdings Limited (20.17B), greater than Valneva SE (527.34M),

Build a custom stock screener for Ascletis Pharma Inc. (ASCLF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Ascletis Pharma Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Ascletis Pharma Inc. (ASCLF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Ascletis Pharma Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Ascletis Pharma Inc.'s Enterprise Value?

What is the highest Enterprise Value for Ascletis Pharma Inc. (ASCLF)?

What is the 3-year average Enterprise Value for Ascletis Pharma Inc. (ASCLF)?

What is the 5-year average Enterprise Value for Ascletis Pharma Inc. (ASCLF)?

How does the current Enterprise Value for Ascletis Pharma Inc. (ASCLF) compare to its historical average?